Zumutor Biologics raises $7.3M Pre-Series B (India, Jun 2026)
Reach the investors backing rounds like this
Backed by Accel, Bharat Innovation Fund +3 more · verified emails and LinkedIn on Datapile
Zumutor biologics secures 7 3 million in pre series b funding - Indiatimes
Zumutor Biologics is a biotech startup focused on developing immuno-oncology therapies that harness the body's innate immune system to fight cancer. The company is advancing its clinical trials for its lead drug candidate ZM008, which is designed to enhance the immune system’s ability to target and destroy cancer cells. This funding round will support ongoing and future clinical trials, including Phase 1 and Phase 2 studies.
Zumutor biologics secures 7 3 million in pre series b funding Indiatimes
| Sep 04, 2026 | Ultrahuman | $70.0M | — | India |
| Sep 04, 2026 | Makr Microsystems | $1.2M | Seed | India |
| Sep 03, 2026 | Slice | $100.0M | — | India |
| Sep 03, 2026 | Comet | $11.8M | Series B | India |
17,638 investors back startups in India
You just read who funded Zumutor Biologics. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.